Yes, Adults with Type 1 Diabetes Must Continuously Adjust Their Insulin Therapy
Adults with type 1 diabetes absolutely require ongoing insulin dose adjustments as a fundamental component of their treatment—this is not optional but essential for achieving glycemic targets while minimizing hypoglycemia and long-term complications. 1
Core Insulin Adjustment Requirements
The 2025 ADA Standards mandate that most adults with type 1 diabetes receive education on matching mealtime insulin doses to carbohydrate, fat, and protein intake, while also modifying insulin doses based on:
- Current blood glucose levels
- Glycemic trends from continuous glucose monitoring
- Anticipated physical activity
- Sick-day management 1
Insulin treatment plans and insulin-taking behavior must be reevaluated at regular intervals (every 3-6 months minimum) and adjusted to incorporate specific factors impacting treatment choice and achievement of individualized glycemic goals. 1
The Evidence Base
The landmark DCCT trial established that intensive insulin therapy with multiple daily injections or continuous subcutaneous insulin infusion requires active dose management and was associated with 50% reductions in microvascular complications over 6 years 1. This benefit depends entirely on the ability to adjust insulin appropriately.
Types of Adjustments Required
Prandial (mealtime) insulin: Adjusted based on carbohydrate counting, fat/protein content, and pre-meal glucose levels 1
Basal insulin: Modified based on fasting glucose patterns and overnight trends—though research shows patients often struggle with basal adjustments independently 2
Correction doses: Applied based on current glycemia to bring elevated glucose back to target 1
Activity-related adjustments: Exercise requires significant insulin modifications; halving basal rates 1 hour before exercise may be insufficient to prevent hypoglycemia in those with low-normal pre-exercise glucose 3
Critical Implementation Challenges
A longitudinal qualitative study revealed that while patients find prandial insulin dose determination relatively straightforward, many struggle over time to determine correct mealtime ratios and adjust basal insulin doses independently 2. Contributing factors include:
- Lack of confidence and poor analytical skills
- Deferential attitudes toward healthcare professionals
- Hypoglycemia anxiety
- Poor record-keeping leading to fixation on current readings rather than pattern recognition 2
Common pitfall: When professional support is not sought and record-keeping is neglected, patients develop over-reliance on corrective doses rather than properly adjusting basal insulin and carbohydrate ratios 2.
Practical Adjustment Framework
Physicians themselves show significant variability in insulin adjustment recommendations—one study found only 41-45% agreement among 26 physicians adjusting basal rates, carbohydrate ratios, and correction factors based on identical patient data 4. This underscores the complexity of insulin adjustment and the need for systematic approaches.
Modern Technology Integration
The 2025 ADA guidelines strongly recommend:
- Automated insulin delivery (AID) systems should be offered to all adults with type 1 diabetes 1
- Early continuous glucose monitoring use to improve glycemic outcomes and minimize hypoglycemia 1
These technologies still require user input for meal announcements and activity adjustments, but they automate much of the basal insulin adjustment that patients find most challenging 2.
Special Circumstances Requiring Adjustment
Adjunctive therapies: When adding medications like tirzepatide to insulin regimens, immediate insulin dose reduction of approximately 25% of total daily dose is recommended at initiation for those with baseline HbA1c <7.5% using AID systems 5. Discontinuation of such agents results in deterioration of glycemic control within 12 weeks, requiring upward insulin adjustment 6.
Exercise management: Requires proactive basal rate reductions (often >50%) plus potential carbohydrate supplementation, particularly for those starting with glucose <6 mmol/L 3. The 2026 DDG/ÖDG guidelines provide system-specific recommendations for each available AID system 7.
The Bottom Line
Insulin adjustment is not a one-time event but an ongoing process requiring patient education, regular professional review, sustained record-keeping, and increasingly, technological support through AID systems. The expectation that adults with type 1 diabetes will independently and continuously adjust their insulin is built into current treatment standards, though the evidence clearly shows many need ongoing professional support to do this effectively. 1, 2